Table 3.
Category | Univariable HR (95% CI) | P-value | Multivariable HR (95% CI) | P-value |
---|---|---|---|---|
Age (>60 years vs <60 years) | 1.688 (0.994–2.799) | 0.053 | ||
Smoking history (>3 years vs <3 years) | 0.582 (0.276–1.226) | 0.154 | ||
Clinical stage (III + IV vs I + II) | 2.329 (1.423–3.812) | 0.001 | 2.368 (1.414–3.967) | 0.001 |
Tumor grade (G3 + G4 vs G1 + G2) | 0.798 (0.482–1.320) | 0.379 | ||
Metastasis (M1 vs M0) | 2.450 (0.889–6.749) | 0.083 | ||
hsa-miR-508 (high vs low) | 0.511 (0.315–0.828) | 0.006 | 0.496 (0.298–0.826) | 0.007 |
hsa-miR-509-2 (high vs low) | 0.655 (0.409–1.050) | 0.079 | 0.596 (0.363–0.980) | 0.041 |
hsa-miR-526b (high vs low) | 0.484 (0.294–0.795) | 0.004 | 0.591 (0.350–0.996) | 0.048 |
Abbreviation: CESC, cervical cancer.